The results reveal that a high level of MDM2 (HR= 1.44, 95%CI (1-2.06), p = 0.046) is correlated with poor overall survival in HNSCC patients (Supplementary Figure 2A). This evidence concerns the gene MDM2 and head and neck squamous cell carcinoma.